Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 3
1992 5
1993 5
1994 7
1995 9
1996 9
1997 4
1998 6
1999 5
2000 5
2001 10
2002 4
2003 6
2004 5
2005 4
2006 7
2007 7
2008 6
2009 3
2010 5
2011 5
2012 6
2013 8
2014 6
2015 9
2016 5
2017 11
2018 12
2019 4
2020 14
2021 12
2022 12
2023 7
2024 13
2025 11
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Results by year

Filters applied: . Clear all
Page 1
Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.
Venkatraman A, Opal P. Venkatraman A, et al. Ann Clin Transl Neurol. 2016 Jun 30;3(8):655-63. doi: 10.1002/acn3.328. eCollection 2016 Aug. Ann Clin Transl Neurol. 2016. PMID: 27606347 Free PMC article. Review.
The ataxic syndrome associated with Anti-Yo antibody, or Purkinje cell cytoplasmic antibody type 1 (PCA1), is the most common variant of paraneoplastic cerebellar degeneration (PCD). ...Magnetic resonance imaging of the brain is often normal in …
The ataxic syndrome associated with Anti-Yo antibody, or Purkinje cell cytoplasmic antibody type 1 (PCA1), is the most common …
Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies.
Winklehner M, Bauer J, Endmayr V, Schwaiger C, Ricken G, Motomura M, Yoshimura S, Shintaku H, Ishikawa K, Tsuura Y, Iizuka T, Yokota T, Irioka T, Höftberger R. Winklehner M, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Jul 7;9(4):e200006. doi: 10.1212/NXI.0000000000200006. Print 2022 Jul. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36070310 Free PMC article.
BACKGROUND AND OBJECTIVES: Paraneoplastic cerebellar degeneration (PCD) is characterized by a widespread loss of Purkinje cells (PCs) and may be associated with autoantibodies against intracellular antigens such as Yo or cell surface neuronal antigens such as …
BACKGROUND AND OBJECTIVES: Paraneoplastic cerebellar degeneration (PCD) is characterized by a widespread loss of Purkin …
Roles of CDR2 and CDR2L in Anti-Yo Paraneoplastic Cerebellar Degeneration: A Literature Review.
Martínez Lozada PS, Mancero Montalvo R, Iturralde Carrillo A, Montesdeoca-Lozada M, Rodas JA, Leon-Rojas JE. Martínez Lozada PS, et al. Int J Mol Sci. 2024 Dec 25;26(1):70. doi: 10.3390/ijms26010070. Int J Mol Sci. 2024. PMID: 39795928 Free PMC article. Review.
Paraneoplastic cerebellar degeneration (PCD) is a rapidly progressive, immune-mediated syndrome characterized by the degeneration of Purkinje cells, often associated with the presence of antibodies targeting intracellular antigens within these cells. .
Paraneoplastic cerebellar degeneration (PCD) is a rapidly progressive, immune-mediated syndrome characterized by the
Plasma exchange for treating anti-Yo-associated paraneoplastic cerebellar degeneration: Case report and literature review.
Hu FQ, Shang FR, Liu JJ, Yuan H. Hu FQ, et al. Medicine (Baltimore). 2020 Aug 14;99(33):e21760. doi: 10.1097/MD.0000000000021760. Medicine (Baltimore). 2020. PMID: 32872070 Free PMC article. Review.
RATIONALE: Paraneoplastic cerebellar degeneration (PCD) is a rare neurodegenerative syndrome associated with antibodies targeting the Purkinje cells of the cerebellum. Most cases of anti-Yo-associated PCD occur in females, with <20 cases repo …
RATIONALE: Paraneoplastic cerebellar degeneration (PCD) is a rare neurodegenerative syndrome associated with antibodies …
Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
Key RG, Root JC. Key RG, et al. Psychooncology. 2013 Sep;22(9):2152-5. doi: 10.1002/pon.3270. Epub 2013 Apr 14. Psychooncology. 2013. PMID: 23585287 Review.
Paraneoplastic cerebellar degeneration (PCD) is a paraneoplastic syndrome which destroys Purkinje cells of the cerebellum and causes trunk and limb ataxia, dysarthria, diplopia, and vertigo, which often precede the diagnosis of cancer. ...METHODS: We p
Paraneoplastic cerebellar degeneration (PCD) is a paraneoplastic syndrome which destroys Purkinje cells of the c
[Paraneoplastic cerebellar degeneration].
Chabriat H, Chen QM, Poisson M, Delattre JY. Chabriat H, et al. Rev Neurol (Paris). 1994;150(2):105-14. Rev Neurol (Paris). 1994. PMID: 7863150 Review. French.
Paraneoplastic cerebellar degeneration (PCD) is a rare complication of systemic cancer. PCD may present as a "pure", severe pan-cerebellar syndrome of subacute progression or be only one clinical feature in the setting of extensive CNS disease. ...In t
Paraneoplastic cerebellar degeneration (PCD) is a rare complication of systemic cancer. PCD may present as a "pure", se
Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.
Imai T, Shinohara K, Uchino K, Okuma H, Maki F, Hiruma K, Ariizumi Y, Yamano Y. Imai T, et al. BMC Neurol. 2022 May 2;22(1):165. doi: 10.1186/s12883-022-02684-4. BMC Neurol. 2022. PMID: 35501715 Free PMC article.
BACKGROUND: As a debilitating syndrome, paraneoplastic cerebellar degeneration (PCD) remains challenging to treat. Further, anti-Yo antibody (directed against human cerebellar degeneration-related protein 2) detection in patients w …
BACKGROUND: As a debilitating syndrome, paraneoplastic cerebellar degeneration (PCD) remains challenging to treat. Furt …
Case report: paraneoplastic cerebellar degeneration associated with anti-Yo antibody successfully treated with ofatumumab.
Dou J, Yue X, Ren H, Wang C, Guo S. Dou J, et al. Front Immunol. 2024 Dec 16;15:1476397. doi: 10.3389/fimmu.2024.1476397. eCollection 2024. Front Immunol. 2024. PMID: 39737186 Free PMC article.
Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies represents a rare immune-mediated paraneoplastic neurological syndrome. ...Here, we present a case of PCD with confirmed anti-Yo antibodies, validated thro
Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies represents a rare immune-mediated
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration.
Peter E, Treilleux I, Wucher V, Jougla E, Vogrig A, Pissaloux D, Paindavoine S, Berthet J, Picard G, Rogemond V, Villard M, Vincent C, Tonon L, Viari A, Honnorat J, Dubois B, Desestret V. Peter E, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Jul 12;9(5):e200015. doi: 10.1212/NXI.0000000000200015. Print 2022 Sep. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35821104 Free PMC article.
BACKGROUND AND OBJECTIVES: Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies is a cancer-related autoimmune disease directed against neural antigens expressed by tumor cells. ...
BACKGROUND AND OBJECTIVES: Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies is a canc …
Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report.
Pozas J, Albarrán-Fernández V, González-Campo L, Olmedo-García ME, Corral de la Fuente E, Corral-Corral I, Carrasco Á, Alonso-Gordoa T, Molina-Cerrillo J, Lage-Alfranca Y, Gómez-Rueda A, Garrido P. Pozas J, et al. Transl Lung Cancer Res. 2022 Jul;11(7):1497-1502. doi: 10.21037/tlcr-21-989. Transl Lung Cancer Res. 2022. PMID: 35958343 Free PMC article.
Paraneoplastic cerebellar degeneration (PCD) is one of the most prevalent neurological paraneoplastic syndromes, typically associated with small cell lung cancer (SCLC). ...Despite PCD being commonly associated with anti-Yo, anti-H
Paraneoplastic cerebellar degeneration (PCD) is one of the most prevalent neurological paraneoplastic syndromes,
235 results